| Authors: |
Barber BE; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; University of the Sunshine Coast Clinical Trials, Morayfield, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia., Webster R; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Potter AJ; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Llewellyn S; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Sahai N; University of the Sunshine Coast Clinical Trials, Morayfield, QLD, Australia., Leelasena I; University of the Sunshine Coast Clinical Trials, Morayfield, QLD, Australia., Mathison S; University of the Sunshine Coast Clinical Trials, Morayfield, QLD, Australia., Kuritz K; IntiQuan GmbH, Basel, Switzerland., Flynn J; Medicines for Malaria Venture, Geneva, Switzerland., Chalon S; Medicines for Malaria Venture, Geneva, Switzerland., Marrast AC; Medicines for Malaria Venture, Geneva, Switzerland., Gobeau N; Medicines for Malaria Venture, Geneva, Switzerland., Moehrle JJ; Medicines for Malaria Venture, Geneva, Switzerland. Electronic address: moehrlej@mmv.org. |
